Ropes & Gray has advised Sanofi. Sanofi has entered into a collaboration and global license agreement with EVOQ Therapeutics to develop therapies for autoimmune diseases using...
Sanofi and EVOQ Therapeutics Sign $500 Million Collaboration and Licensing Agreement
Star Therapeutics Closes $125 Million Series D Financing
Ropes & Gray has advised Sanofi Ventures. Star Therapeutics, a clinical stage biotechnology company focused on the discovery and development of best-in-class antibodies for bleeding disorders...
Sanofi and EQT Life Sciences Invest in SpliceBio’s $135 Million Series B Financing
Ropes & Gray has advised Sanofi and EQT Life Sciences on the transaction. Sanofi and EQT Life Sciences have participated in a $135 million Series B...
Draig Therapeutics Secures $140 Million in Total Financing Since Inception
Covington & Burling and Taylor Wessing advised Draig Therapeutics Limited on the transaction, and Ropes & Gray has advised Sanofi. Draig Therapeutics Limited has secured a...
Sanofi Acquires Blueprint Medicines in $9.5 Billion Deal
Weil has advised Sanofi on the deal. Sanofi has announced the acquisition of Blueprint Medicines, a globally recognized, publicly traded biopharmaceutical company. The transaction is valued...
Granite Bio AG’s $100 Million Funding Round
VISCHER advised Forbion and Sanofi Ventures on all legal issues related to the transaction. Granite Bio AG, a clinical-stage immunology company developing first-in-class antibodies that target...
Sanofi’s $1.9 Billion Acquisition of Dren Bio’s Bispecific Antibody-Based Program
Ropes & Gray represented Sanofi in the transaction. Sanofi announced an agreement to acquire Dren Bio’s deep B-cell depleter program, DR-0201. The targeted bispecific myeloid cell...
Curevo’s $110 Million Series B Financing Round
Ropes & Gray represented Sanofi Ventures in the transaction. Curevo Vaccine (Curevo) announced raising $110 million in Series B financing. Leading the round is new investor...
Atalanta Therapeutics’ $97 Million Series B Financing Round
Ropes & Gray represented Sanofi in the transaction. Atalanta Therapeutics announced it has raised $97 million in Series B financing. The financing was co-led by EQT...
STADA’s Acquisition of Consumer Healthcare Brands
Jones Day advised Sanofi on the transaction. STADA announced its acquisition of 7 consumer healthcare brands from Sanofi across several countries, including Belgium, Germany, Hungary, Spain, the U.K.,...